“Expert Clinical Framework Report: Management of Adverse Events Related to Novel Therapies for Relapsed Refractory Multiple Myeloma (RRMM)”. Canadian Hematology Today 1, no. S11 (November 15, 2022). Accessed April 21, 2026. https://canadianhematologytoday.com/article/view/30.